𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia

✍ Scribed by I.-M. Huhmann; H. H. Watzke; K. Geissler; H. Gisslinger; U. Jäger; P. Knöbl; I. Pabinger; L. Korninger; C. Mannhalter; G. Mitterbauer; I. Schwarzinger; P. Kalhs; O. A. Haas; K. Lechner

Publisher
Springer
Year
1996
Tongue
English
Weight
192 KB
Volume
73
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine and cytosine arabinoside in
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia
✍ Samer Suki; Hagop Kantarjian; Varsha Gandhi; Elihu Estey; Susan O'Brien; Milosla 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB

## Background: The objectives of the study were to evaluate the antileukemic efficacy and toxicity profiles of the combination of fludarabine and intermediate-dose cytosine arabinoside (ara-c) in refractory or relapsed adult acute lymphocytic leukemia (all). patients and methods. thirty adults with

FLAG (fludarabine, high-dose cytarabine,
FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children
✍ McCarthy, A.J.; Pitcher, L.A.; Hann, I.M.; Oakhill, A. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

Background. The treatment of relapsed and refractory leukemia in children remains a challenge. The morbidity of further chemotherapy is considerable, as most patients have already been exposed to intensive multiagent chemotherapy. The FLAG (fludarabine, high-dose cytarabine, and G-CSF) regimen is as

Fludarabine, cytarabine, and G-CSF (FLAG
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
✍ Montillo, Marco; Mirto, Salvatore; Petti, Maria Concetta; Latagliata, Roberto; M 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Thirty-eight patients with primary resistant or relapsing acute myeloid leukemia (AML) were treated with fludarabine, cytarabine and granulocyte colony-stimulating factor (FLAG). Median age was 41 (range 11-70). Sixteen patients had AML that was primary resistant to induction treatment, while 22 wer

Letter to the Editor:FLAG (fludarabine,
Letter to the Editor:FLAG (fludarabine, high-dose cytarabine and G-CSF) for refractory and high-risk relapsed acute leukemia in children
✍ Sarper, Nazan; Yalman, Nevin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

## FLAG (Fludarabine, High-Dose Cytarabine and G-CSF) for Refractory and High-Risk Relapsed Acute Leukemia in Children We have read with interest the report about FLAG therapy in childhood acute leukemia by McCarthy et al. [1]. We want to add our experience with IDA-FLAG in poor-risk childhood leuk